Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11174267
Spiroindolinones and therapeutic uses thereof
granted -
US 11174262
Compounds, compositions and methods
granted -
US 11174251
Compositions and methods for inhibition of the JAK pathway
granted -
US 11174486
Engineered bacteria for production and release of therapeutics
granted -
US 11174268
Benzenesulfonamide compouds and their use as therapeutic agents
granted -
US 11174283
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11174246
Direct AMPK activators
granted -
US 11174219
Neprilysin inhibitors
granted -
US 11174212
2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
granted -
US 11173291
Implantable drug delivery devices for localized drug delivery
granted -
US 11173235
Nitrite eluting devices and methods of use thereof
granted -
US 11173183
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11173208
Liquid formulation comprising GM-CSF neutralizing compound
granted -
US 11173207
Adjuvant compositions
granted -
US 11173201
Methods and compositions for inducing protective immunity against filovirus infection
granted -
US 11173165
Optimizing mifepristone levels for Cushing's patients
granted -
US 11173161
4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
granted -
US 11173159
Methods and compositions for inhibition of polymerase
granted -
US 11173150
Method for diagnosing, preventing, and treating neurological diseases
granted -
US 11173147
Prophylactic or therapeutic agent for delirium
granted -
US 11173145
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
granted -
US 11173164
Compositions comprising triterpenoids
granted -
US 11173136
Method for modulating metabolism
granted -
US 11173129
Nanowire-coated microdevice and method of making and using the same
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.